Answers are grounded in this paper and cite their sources.
This review aims to cover the transplant procedures that have been developed and investigated as potential treatments for age-related macular degeneration. The choice of transplant materials that will be discussed ranges from isolated cells (including stem cells, iris pigment epithelial cells and retinal pigment epithelial cells) to monolayers of cells on artificial or nonartificial substrates and also to whole patches of tissue (e.g., fetal retina, full-thickness patch grafts and macular relocation). Finally, we will address the current and future technologies and questions that need to be addressed in order that transplant procedures can have an effective role in the treatment of patients with age-related macular degeneration.
No takes yet. Share an insight, caveat, or question.
Sheridan et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: